Bio-pharmaceutical Technology
www.china-pdl.net
Inventor: Dr. Qiu Xiaoqing
Pheromonicin® Biotech (BVI 2010, HK 2011, Beijing 2012, Los Angeles 2013).
Investment: Series A since 2010, currently on Tranche-II.
Features: The new drugs are especially effective for guided kills to drug-resistant bacterial infections and hard-separate bio cells in forms of bacteria, fungi, algae and tumors. Revolutionary bioengineering approaches made the future new drugs free of toxic, side effects, drug-resist development, more effective and powerful in orders of magnitude. World patents with US and China origin, spread over 70+ world regions, already 30+ of invention patents, and major refined and continuing inventions extende covers of earlier inventions.
Seeking for international regional partners (investors and development team) for new drug R$D team, manufacture licensees, technology transfer and financial investments, to have JVs in China and the world.
Pheromonicin®